Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001140361-17-029431

Options or other derivatives

  • Director acquired 1,127 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
KIRK RANDAL J Director 2017-07-31 Other acquisition · Series 1 Preferred Stock +1,127 113,840 I
Loading xslF345X03/doc1.xml…